Amentum Holdings Inc (AMTM) is not a strong buy at the moment for a beginner investor with a long-term focus and $50,000-$100,000 to invest. The stock lacks clear positive catalysts, has mixed financial performance, and no strong trading signals. A hold is recommended until more favorable conditions emerge.
The stock's MACD is below zero and negatively contracting, indicating bearish momentum. RSI is neutral at 22.805, and moving averages are converging, showing no clear trend. Key support is at $26.334, with resistance at $28.137. The stock is trading close to its support level, but no strong technical buy signal is present.

Analyst BofA raised the price target to $30, citing improved investor sentiment and the company's nuclear exposure premium. Net income and EPS have shown significant YoY growth in the latest quarter.
Hedge funds are selling heavily, with a 3056.33% increase in selling over the last quarter. Revenue has dropped by -5.24% YoY, and the stock lacks any significant insider or congress trading activity. Broader market sentiment is negative, with the S&P 500 down -1.79%.
In Q1 2026, revenue dropped by -5.24% YoY to $3.237 billion. However, net income increased by 266.67% YoY to $44 million, and EPS rose by 260.00% YoY to $0.18. Gross margin improved slightly to 7.17%, up 1.56% YoY, indicating some operational efficiency gains.
BofA raised the price target from $27 to $30, maintaining a Neutral rating. The analyst highlights the company's nuclear exposure as a positive factor but notes uncertainties in civilian agency funding heading into 2026.